Contineum Therapeutics, Inc. Class A Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Contineum Therapeutics, Inc. Class A Common Stock's balance sheet done over the years? Its assets were worth $130,386,000 last year. 152% of Contineum Therapeutics, Inc. Class A Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $198,322,000.
Debt to Assets
| 2023 | 130386000 | 198.32M | 152.1% |
|---|
CTNM Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 15.52M |
Short term investments | 109.66M |
Net receivables | 0 |
Inventory | 0 |
Other current assets | 2.51M |
Total current assets | 127.70M |
Non-current assets: | |
Property, Plant and Equipment | 1.39M |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 1.28M |
Total non-current assets | 2.68M |
Total assets | 130.38M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 464K |
Total current liabilities | 5.48M |
| Non-current liabilities: | |
Long term debt | 192.72M |
Deferred tax | 0 |
Other non-current liabilities | 110K |
Total non-current liabilities | 192.83M |
Total liabilities | 198.32M |